\-\ Texto\\:\\ \ \(0\)\
\-\ obtundation\\ and\\ fever\ \(0\)\
\-\ high\\ dose\\ \\ iv\\ antibiotics\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ cerebral\\ and\\ cerebellar\\ ring\\ enhancing\\ lesions\\ most\\ of\\ which\\ are\\ associated\\ with\\ restricted\\ diffusion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ gyral\\ enhancement\\ left\\ frontal\\ lobe\\.\ \(0\)\
\-\ multifocal\\ brain\\ abscess\\,\\ septic\\ emboli\\ from\\ endocarditis\ \(0\)\
\-\ \\â\\€\\¢\\ encephalitis\ \(1\)\
\-\ \\â\\€\\¢\\ ischemic\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ septic\\ emboli\\ and\\ brain\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ toxoplasmosis\ \(0\)\
\-\ 62\\ year\\ old\\ man\\ with\\ fever\\ and\\ positive\\ blood\\ cultures\\.\\ \\ endocarditis\\ suspected\\ clinically\\.\\ noted\\ to\\ have\\ declining\\ level\\ of\\ consciousness\\ in\\ icu\\ over\\ past\\ 24\\ hours\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endocarditis\\:\\ 0\\.1385663369145835\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1305845292996573\ \(0\)\
\-\ emboli\\:\\ 0\\.11013961147476362\ \(0\)\
\-\ septic\\:\\ 0\\.10678059723048017\ \(0\)\
\-\ obtundation\\:\\ 0\\.0801913914557936\ \(0\)\
\-\ declining\\:\\ 0\\.07878921245988427\ \(0\)\
\-\ gyral\\:\\ 0\\.07536442588307735\ \(0\)\
\-\ fever\\:\\ 0\\.06883958634647538\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.06527754659275349\ \(0\)\
\-\ abscess\\:\\ 0\\.06432943438414922\ \(0\)\
\-\ brain\\:\\ 0\\.061222655316732426\ \(0\)\
\-\ icu\\:\\ 0\\.06073745663407369\ \(0\)\
\-\ encephalitis\\:\\ 0\\.056815085192047\ \(0\)\
\-\ 62\\:\\ 0\\.055623615447321015\ \(0\)\
\-\ multifocal\\:\\ 0\\.05471441331893323\ \(0\)\
\-\ dose\\:\\ 0\\.05323467859658112\ \(0\)\
\-\ cultures\\:\\ 0\\.05234140257345119\ \(0\)\
\-\ consciousness\\:\\ 0\\.051645019160574894\ \(0\)\
\-\ ischemic\\:\\ 0\\.049542358021535414\ \(0\)\
\-\ ring\\:\\ 0\\.04727775401795127\ \(0\)\
\-\ restricted\\:\\ 0\\.046818053587858656\ \(0\)\
\-\ diffusion\\:\\ 0\\.04553673615699716\ \(0\)\
\-\ clinically\\:\\ 0\\.04460255025888413\ \(0\)\
\-\ cerebellar\\:\\ 0\\.043876425107659815\ \(0\)\
\-\ suspected\\:\\ 0\\.043806190320431385\ \(0\)\
\-\ infarction\\:\\ 0\\.04157748148604869\ \(0\)\
\-\ hours\\:\\ 0\\.04000234891200948\ \(0\)\
\-\ 24\\:\\ 0\\.03955305929316606\ \(0\)\
\-\ antibiotics\\:\\ 0\\.03821090901988691\ \(0\)\
\-\ iv\\:\\ 0\\.03712410639834635\ \(0\)\
\-\ cerebral\\:\\ 0\\.03524341073528656\ \(0\)\
\-\ positive\\:\\ 0\\.03301054274147758\ \(0\)\
\-\ past\\:\\ 0\\.032323803237457545\ \(0\)\
\-\ frontal\\:\\ 0\\.03195585636289711\ \(0\)\
\-\ enhancing\\:\\ 0\\.03190420872481856\ \(0\)\
\-\ level\\:\\ 0\\.029320107471987284\ \(0\)\
\-\ high\\:\\ 0\\.02783983406043828\ \(0\)\
\-\ blood\\:\\ 0\\.027766798482253562\ \(0\)\
\-\ lobe\\:\\ 0\\.027372920808613498\ \(0\)\
\-\ enhancement\\:\\ 0\\.02726772340622662\ \(0\)\
\-\ lesions\\:\\ 0\\.02723286317076128\ \(0\)\
\-\ over\\:\\ 0\\.025900507025475743\ \(0\)\
\-\ metastatic\\:\\ 0\\.02560844528114393\ \(0\)\
\-\ noted\\:\\ 0\\.02411215700538802\ \(0\)\
\-\ man\\:\\ 0\\.024058712417738083\ \(0\)\
\-\ associated\\:\\ 0\\.024005506689377402\ \(0\)\
\-\ most\\:\\ 0\\.02348613263961995\ \(0\)\
\-\ have\\:\\ 0\\.022029024742441568\ \(0\)\
\-\ multiple\\:\\ 0\\.02142626194618177\ \(0\)\
\-\ which\\:\\ 0\\.018989816514792247\ \(0\)\
\-\ disease\\:\\ 0\\.016627827871615524\ \(0\)\
\-\ from\\:\\ 0\\.015076615632788242\ \(0\)\
\-\ are\\:\\ 0\\.013867546101542876\ \(0\)\
\-\ left\\:\\ 0\\.011382205586582317\ \(0\)\
\-\ year\\:\\ 0\\.011382205586582317\ \(0\)\
\-\ old\\:\\ 0\\.010415888057883982\ \(0\)\
\-\ and\\:\\ 0\\.008571857415819926\ \(0\)\
\-\ to\\:\\ 0\\.0050841441481307885\ \(0\)\
\-\ in\\:\\ 0\\.005016633692145891\ \(0\)\
\-\ \\,\\:\\ 0\\.003222738875205802\ \(0\)\
\-\ with\\:\\ 0\\.0027858137164259457\ \(0\)\
\-\ of\\:\\ 0\\.0027739000189997243\ \(0\)\
\-\ \\.\\:\\ 0\\.0021130676248420402\ \(0\)\
